Development of vaccines against Crimean-Congo haemorrhagic fever virus.

about

Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.

P2860

Q51782982-789D6DE1-C517-4031-BFC4-086EFDB94761

P2860

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

Item

http://www.wikidata.org/entity/Q38688993

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

@en

type

Item

label

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

@en

prefLabel

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

@en

P1476

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

@en

P2093

Miles W Carroll

http://www.w3.org/2001/XMLSchema#string

Roger Hewson

http://www.w3.org/2001/XMLSchema#string

Stuart D Dowall

http://www.w3.org/2001/XMLSchema#string

P2860

Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice

A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model

Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins.

Consensus report: Preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival

Potential benefits of cattle vaccination as a supplementary control for bovine tuberculosis

Structure, Function, and Evolution of the Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein

Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells

Crimean-Congo haemorrhagic fever

Iraq's biological weapons. The past as future?

Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin

P304

6015-6023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.VACCINE.2017.05.031

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28687403

http://www.w3.org/2001/XMLSchema#string

P921

Crimean-Congo hemorrhagic fever

Crimean-Congo hemorrhagic fever virus

Añaw

P932

5637709

http://www.w3.org/2001/XMLSchema#string

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

about

P2860

P2860

Development of vaccines against Crimean-Congo haemorrhagic fever virus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932